We remain open to provide medically necessary, life-sustaining care. Please read our COVID-19 updates before coming in for an appointment. Our expert care team can now see patients through scheduled virtual appointments on a secure platform from the comfort and safety of your home.

Christopher DiSimone, MD, PhD Christopher DiSimone, MD, PhD

Christopher DiSimone, MD, PhD

Medical Oncology & Hematology

Patient Portal


Tucson - Wilmot Road

Tucson - Wilmot Road

603 N. Wilmot Rd. #151
Tucson, AZ 85711
View Map
Call: 520-886-0206
Fax: 520-886-0829

Education & Credentials


Johns Hopkins University

Medical School

University of California-Davis


University of California-San Diego


University of California-San Diego


Hematology and Oncology at University of California-San Diego

Board Certification

Medical Oncology and Hematology

Academic Honors & Professional Achievements

Among Dr. DiSimone's honors and fellowships are undergraduate honors from Johns Hopkins University, NIH Predoctoral and Postdoctoral fellowships, and receipt of the Edward M. Gold Award, signifying UC Davis’ most outstanding student in medicine. Dr. DiSimone's research has been published in Virology, Vaccines, and BMC Microbiology. In recent years, he has contributed to multiple presentations at national conferences on new drug development. 



In The Media


Dr. DiSimone specializes in treating patients with all types of cancer. He holds a longstanding interest in the treatment of prostate, bladder, kidney, and testicular cancer, and supervises the TMC GU Tumor Board.  

Dr. DiSimone earned a bachelor’s degree with honors in chemistry at Johns Hopkins University and a Ph.D in chemistry at Cal Tech in Pasadena, California. He earned his medical degree from UC Davis and completed his residency in internal medicine at University of California-San Diego, where he served as a hematology and oncology fellow. Dr. Di Simone also served as faculty at Scripps Research Institute after completing research at Cal Tech and Johns Hopkins. 


Dr. DiSimone is dedicated to bringing the newest clinical approaches to patient treatment, with particular interest in clinical trials. He is a long-term site research leader for Arizona Oncology, and serves on the US Oncology research committee directing clinical trials. 

Arizona Oncology - The US Oncology Network